CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja
Intest Res. 2018;16(4):588-598.   Published online October 10, 2018
DOI: https://doi.org/10.5217/ir.2018.00023

Excel Download

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
Intestinal Research. 2018;16(4):588-598   Crossref logo
Link1 Link2 Link3

Sa1717 - Very High Rate of Tuberculosis Complicating Infliximab Therapy for Inflammatory Bowel Disease Despite Tuberculosis Screening in India
Gastroenterology. 2018;154(6):S-367   Crossref logo
Link1 Link2

Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening
Australasian Journal of Dermatology. 2013;55(2):140-141   Crossref logo
Link1

P016 IMPROVING TUBERCULOSIS RE SCREENING IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY: A SINGLE CENTER QUALITY IMPROVEMENT INITIATIVE.
Inflammatory Bowel Diseases. 2020;26(Supplement_1):S52-S53   Crossref logo
Link1 Link2

Su1150 – Risk of Tuberculosis in Patients with Inflammatory Bowel Disease on Infliximab Or Adalimumab is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis
Gastroenterology. 2019;156(6):S-516-S-517   Crossref logo
Link1 Link2

P016 IMPROVING TUBERCULOSIS RE SCREENING IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY: A SINGLE CENTER QUALITY IMPROVEMENT INITIATIVE.
Gastroenterology. 2020;158(3):S84   Crossref logo
Link1 Link2

Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases. 2018;24(6):1272-1273   Crossref logo
Link1

Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases. 2018;24(6):1266-1271   Crossref logo
Link1

Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease
Cancer Screening in Inflammatory Bowel Disease. 2019;33-53   Crossref logo
Link1

Su1854 – Profile of Patients with Inflammatory Bowel Disease Who Developed Active Tuberculosis Despite Negative Screening Prior to the Introduction of Anti-TNF Therapy
Gastroenterology. 2019;156(6):S-636   Crossref logo
Link1 Link2